SH T 586
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for SH T 586, covering 2013-12-04 to 2013-12-04. Get the full timeline:
Most recent: Clinical Trial Update: Efficacy and Safety Study of SH T 586 in Combination With Rituximab to Treat Low-Grade NHL [Phase 2]